Amedisys Inc  

(Public, NASDAQ:AMED)   Watch this stock  
Find more results for AMED
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 13.25 - 31.27
Open     -
Vol / Avg. 0.00/183,742.00
Mkt cap 975.71M
P/E     -
Div/yield     -
EPS -0.31
Shares 33.67M
Beta 1.05
Inst. own 93%
Jul 28, 2015
Q2 2015 Amedisys Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 4, 2015
Amedisys Inc Annual Shareholders Meeting - 1:00PM EDT - Add to calendar
May 12, 2015
Amedisys Inc at Bank of America Merrill Lynch Health Care Conference - Webcast
Apr 29, 2015
Q1 2015 Amedisys Inc Earnings Call - Webcast
Apr 29, 2015
Q1 2015 Amedisys Inc Earnings Release
Mar 4, 2015
Q4 2014 Amedisys Inc Earnings Call - Webcast
Mar 4, 2015
Q4 2014 Amedisys Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -11.55% 1.10%
Operating margin -19.27% 2.00%
EBITD margin - 4.61%
Return on average assets -21.61% 1.91%
Return on average equity -36.77% 3.38%
Employees 13,200 -
CDP Score - -


United States - Map
+1-225-2922031 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Amedisys, Inc. (Amedisys) is a health care at home company. The Company delivers personalized home health and hospice care to approximately 360,000 patients each year. It is focused on delivering patient-centered care, whether that is home-based recovery and rehabilitation after an operation or injury, care focused to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. The Company owns and operates approximately 367 Medicare-certified home health care centers, 92 Medicare-certified hospice care centers and one hospice inpatient unit. The Company operates in two segments: home health and hospice. Home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgical procedure. Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness.

Officers and directors

Paul B. Kusserow President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Ronald A. LaBorde Vice Chairman of the Board, Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Dan McCoy Chief Operating Officer
Bio & Compensation  - Reuters
Larry Pernosky Chief Human Resource Officer
Bio & Compensation  - Reuters
David L. Kemmerly Senior Vice President - Government Affairs, Interim General
Bio & Compensation  - Reuters
Martin Howard Chief Information Officer
Bio & Compensation  - Reuters
Jeffrey D. Jeter J.D. Chief Compliance Officer
Age: 43
Bio & Compensation  - Reuters
Stephen Seim Chief Strategy Officer
Bio & Compensation  - Reuters
Donald A. Washburn Non-Executive Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Linda J. Hall Independent Director
Age: 66
Bio & Compensation  - Reuters